Literature DB >> 9033644

Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine.

M Arai1, S Shimizu, Y Imai, Y Nakatsuru, H Oda, T Oohara, T Ishikawa.   

Abstract

In contrast to the origins of colorectal carcinomas, the mechanisms of carcinogenesis in the small intestine remain unclear. We therefore analyzed the mutational status of the Ki-ras, p53, and adenomatous polyposis coli (APC) genes in primary carcinomas of the small intestine and compared the mutation patterns with those established for colorectal cancers. DNA was extracted from 15 formalin-fixed, paraffin-embedded lesions. Codons 12, 13 and 61 of the Ki-ras gene, exons 5-8 of the p53 gene, and codons 1268-1569, which contain the mutation cluster region (MCR) of the APC gene, were amplified by means of PCR, subcloned and sequenced. Mutations of the Ki-ras and p53 genes were observed in 8 (53.3%) and 4 lesions (26.7%), respectively. The mutational frequency of the Ki-ras gene in the present series of small intestinal carcinomas was similar, while that of the p53 gene was slightly lower than the reported frequencies for colorectal carcinomas. Only one case showed a mutation of the APC gene, involving an insertional mutation of an adenine at codons 1554-1556 with formation of a stop codon immediately downstream. Since the occurrence of an APC mutation is considered an early event in colorectal carcinogenesis, our findings indicating an extremely low frequency of such changes in and around the MCR suggest that carcinomas of the small intestine arise via a genetic pathway distinct from that involved in the development of carcinomas of the colorectum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9033644     DOI: 10.1002/(sici)1097-0215(19970207)70:4<390::aid-ijc3>3.0.co;2-r

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Combination analysis of genetic alterations and cell proliferation in small intestinal carcinomas.

Authors:  T Muneyuki; M Watanabe; M Yamanaka; S Isaji; Y Kawarada; R Yatani
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

2.  Frequent Ki-ras mutations and transforming growth factor-alpha expression in adenocarcinomas of the small intestine: report of 7 cases.

Authors:  Hiroyuki Mitomi; Takatoshi Nakamura; Atsushi Ihara; Yoshimasa Otani; Miwa Sada; Masahiro Igarashi; Fumiyuki Akino; Masaaki Ichinoe; Tatsuya Ojima; Akio Mori; Isao Okayasu
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

3.  A 72-year-old man with duodenal adenocarcinoma.

Authors:  Sally Tamraz; Ali Shamseddine; Manish Shah; Mohamed El-Oubeidi; Ghazi Zaatari; Fady Geara; Maeve A Lowery; Eileen M O'Reilly; Aghiad Al-Kutoubi; Walid Faraj; David P Kelsen; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2012-05

4.  Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.

Authors:  Reiko Kumagai; Kenichi Kohashi; Shunsuke Takahashi; Hidetaka Yamamoto; Minako Hirahashi; Kenichi Taguchi; Kenichi Nishiyama; Yoshinao Oda
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

5.  A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease.

Authors:  Michael J Overman; Chung-Yuan Hu; Scott Kopetz; James L Abbruzzese; Robert A Wolff; George J Chang
Journal:  Ann Surg Oncol       Date:  2011-12-21       Impact factor: 5.344

6.  An insight into the genetic pathway of adenocarcinoma of the small intestine.

Authors:  J M D Wheeler; B F Warren; N J McC Mortensen; H C Kim; S C Biddolph; G Elia; N E Beck; G T Williams; N A Shepherd; A C Bateman; W F Bodmer
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

7.  Duodenal carcinoma at the ligament of Treitz. A molecular and clinical perspective.

Authors:  Peter T Kalogerinis; John E Poulos; Andrew Morfesis; Anthony Daniels; Stavroula Georgakila; Thomas Daignualt; Alexandros G Georgakilas
Journal:  BMC Gastroenterol       Date:  2010-09-17       Impact factor: 3.067

8.  Cetuximab in small bowel adenocarcinoma: a new friend?

Authors:  D Santini; M E Fratto; C Spoto; A Russo; S Galluzzo; A Zoccoli; B Vincenzi; G Tonini
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

9.  Recent advances in the management of adenocarcinoma of the small intestine.

Authors:  Michael J Overman
Journal:  Gastrointest Cancer Res       Date:  2009-05

10.  Sporadic duodenal adenoma is associated with colorectal neoplasia.

Authors:  M A Murray; M J Zimmerman; H C Ee
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.